• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/40; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/40; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 391020
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/21/2019
Event Type  malfunction  
Event Description
Ous mdr - an orsiro drug-eluting stent system was selected for use.During stent positioning backflow of blood was observed.Therefore the device was removed from the patient's body and another device was used for the procedure.
 
Event Description
Ous mdr an orsiro drug-eluting stent system was selected for use.During stent positioning backflow of blood was observed.Therefore the device was removed from the body and another device was used for the procedure.
 
Manufacturer Narrative
The returned instrument was subjected to a detailed technical analysis and the corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The technical investigation of the returned orsiro revealed that the balloon is well folded and shows no signs of inflation.The stent is crimped between the x-ray markers.During microscopic analysis no leakage or damage was detected.Due to dried residue the complaint device could not be inflated even after immersing into decontamination liquid for three days.The device is clogged and therefore a leakage could not be identified.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.As a part of final inspection each instrument is tested for air tightness by means of a helium leak test.We can therefore confirm that the instrument was delivered in a leak-proof condition.Based on the conducted investigations of the device being subject to this complaint, no manufacturing or material related root cause was determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 3.5/40
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key8515115
MDR Text Key141959603
Report Number1028232-2019-01484
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130439450
UDI-Public07640130439450
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/15/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/06/2020
Device Model Number391020
Device Catalogue NumberSEE MODEL NO.
Device Lot Number07182876
Date Manufacturer Received05/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-